Keyphrases
Arthritis
100%
Inflammation
100%
Tumor Necrosis Factor Genes
100%
Adenovirus
100%
Gene Expression
100%
Anti-tumor Necrosis Factor (anti-TNF)
100%
Serotype 5
100%
Intra-articular Injection
100%
Recombinant Adeno-associated Virus (rAAV)
80%
Virus Serotype
80%
Tumor Necrosis Factor-α
60%
NF-B
60%
Collagen-induced Arthritis
40%
Factor Approach
40%
Extracellular Domain
40%
Rheumatoid Arthritis
20%
Rheumatoid Arthritis Treatment
20%
Intra-articular
20%
Gene Transfer
20%
AAV5
20%
Biotherapy
20%
Recombinant
20%
Disease Onset
20%
Joint Damage
20%
Targeted Tumor
20%
Intra-articular Administration
20%
Long-term Safety
20%
Disease Flare
20%
Tumor Necrosis Factor Antagonist
20%
TNFRp55
20%
Inflammation-responsive
20%
Fc Region
20%
Anti-tumor Necrosis Factor Agents
20%
Small Molecular
20%
CMV Promoter
20%
Transient Expression
20%
Safety Concerns
20%
Vector Encoding
20%
IgG1
20%
Medicine and Dentistry
Serotype
100%
Arthritis
100%
Adeno Associated Virus 5
100%
Tumor Necrosis Factor
100%
Gene Expression
100%
Intra-Articular Injection
100%
Promoter Region
62%
Adeno-Associated Virus
50%
Rheumatoid Arthritis
25%
Collagen-Induced Arthritis
25%
Inflammatory Arthritis
25%
Disease
12%
Gene Transfer
12%
Joint Injection
12%
Biological Therapy
12%
Disease Exacerbation
12%
Transient Expression
12%
Immunoglobulin G1
12%
TNF Inhibitor
12%
Immunology and Microbiology
Arthritis
100%
Serotype
100%
Gene Expression
100%
Tumor Necrosis Factor
100%
Adeno Associated Virus 5
100%
Promoter Region
62%
Adeno Associated Virus
50%
Inflammatory Arthritis
25%
Gene Transfer
12%
TNF Inhibitor
12%
Immunoglobulin G1
12%
Molecular Weight
12%
Transient Expression
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Arthritis
100%
Inflammation
100%
Adeno Associated Virus 5
100%
Adeno Associated Virus
50%
Rheumatoid Arthritis
25%
Collagen-Induced Arthritis
25%
Inflammatory Arthritis
25%
Disease
12%
Disease Exacerbation
12%
Immunoglobulin G1
12%
Tumor Necrosis Factor Inhibitor
12%
Gene Delivery
12%